Taiyen Biotech Co Ltd (1737) — Cash Flow Reinvestment Rate
Taiyen Biotech Co Ltd (1737) has a Cash Flow Reinvestment Rate of 0.57x as of December 2025, reinvesting NT$110.72 Million (capex NT$101.72 Million plus investments NT$-9.00 Million) from operating cash flow of NT$194.08 Million. Explore Taiyen Biotech Co Ltd (1737) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Taiyen Biotech Co Ltd Cash Flow Reinvestment Rate (2003–2025)
Historical reinvestment intensity for Taiyen Biotech Co Ltd across 23 annual periods. Also explore 1737 current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Taiyen Biotech Co Ltd (2003–2025)
Year-by-year capital reinvestment analysis for Taiyen Biotech Co Ltd. For live market cap and broader valuation context, see 1737 market cap.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.69x | NT$328.17 Million | NT$473.77 Million | NT$300.16 Million | ▲ +42.1% |
| 2024 | 0.49x | NT$321.68 Million | NT$660.12 Million | NT$307.61 Million | ▼ -67.6% |
| 2023 | 1.51x | NT$684.43 Million | NT$454.54 Million | NT$345.13 Million | ▲ +252.8% |
| 2022 | 0.43x | NT$247.87 Million | NT$580.69 Million | NT$246.60 Million | ▼ -39.0% |
| 2021 | 0.70x | NT$419.61 Million | NT$600.08 Million | NT$390.81 Million | ▼ -11.8% |
| 2020 | 0.79x | NT$269.06 Million | NT$339.36 Million | NT$267.89 Million | ▼ -36.3% |
| 2019 | 1.24x | NT$411.65 Million | NT$330.81 Million | NT$284.25 Million | ▲ +63.1% |
| 2018 | 0.76x | NT$343.19 Million | NT$449.83 Million | NT$298.49 Million | ▼ -16.0% |
| 2017 | 0.91x | NT$551.88 Million | NT$607.87 Million | NT$369.68 Million | ▲ +6.9% |
| 2016 | 0.85x | NT$482.65 Million | NT$568.06 Million | NT$190.30 Million | ▲ +130.0% |
| 2015 | 0.37x | NT$141.84 Million | NT$383.93 Million | NT$106.57 Million | ▼ -54.5% |
| 2014 | 0.81x | NT$300.97 Million | NT$371.06 Million | NT$148.81 Million | ▼ -34.1% |
| 2013 | 1.23x | NT$250.23 Million | NT$203.21 Million | NT$93.53 Million | ▲ +73.8% |
| 2012 | 0.71x | NT$109.40 Million | NT$154.46 Million | NT$109.40 Million | ▲ +126.8% |
| 2011 | 0.31x | NT$76.85 Million | NT$246.09 Million | NT$76.85 Million | ▼ -25.5% |
| 2010 | 0.42x | NT$126.08 Million | NT$300.89 Million | NT$126.08 Million | ▲ +30.8% |
| 2009 | 0.32x | NT$114.67 Million | NT$358.02 Million | NT$114.67 Million | ▼ -30.4% |
| 2008 | 0.46x | NT$192.08 Million | NT$417.51 Million | NT$192.08 Million | ▲ +86.2% |
| 2007 | 0.25x | NT$79.70 Million | NT$322.49 Million | NT$79.70 Million | ▼ -22.9% |
| 2006 | 0.32x | NT$148.45 Million | NT$462.88 Million | NT$148.45 Million | ▲ +43.0% |
| 2005 | 0.22x | NT$129.19 Million | NT$575.91 Million | NT$129.19 Million | ▲ +229.6% |
| 2004 | 0.07x | NT$192.93 Million | NT$2.84 Billion | NT$192.93 Million | ▲ +146.5% |
| 2003 | 0.03x | NT$94.39 Million | NT$3.42 Billion | NT$94.39 Million | — |